Explore
Trendline
Bunge Reports Strong Q1 2026 Results with Increased EPS Outlook
Bunge Reports Strong Q1 2026 Results with Increased EPS Outlook
Read More
Trendline
PPG Industries Reports Strong Q1 2026 Financial Performance
PPG Industries Reports Strong Q1 2026 Financial Performance
Read More
Trendline
Wingstop Inc. Reports Q1 2026 Financial Results Highlighting System-Wide Sales Growth
Wingstop Inc. Reports Q1 2026 Financial Results Highlighting System-Wide Sales Growth
Read More
Trendline
Meta Reports Strong Financial Performance in Q1 2026 Amidst Strategic Developments
Meta Reports Strong Financial Performance in Q1 2026 Amidst Strategic Developments
Read More
Trendline
Keurig Dr Pepper Focuses on Beverage Innovation Amidst Financial Challenges
Keurig Dr Pepper Focuses on Beverage Innovation Amidst Financial Challenges
Read More
Trendline
Simpson Manufacturing Reports 9.1% Increase in Q1 2026 Net Sales Amid Market Challenges
Simpson Manufacturing Reports 9.1% Increase in Q1 2026 Net Sales Amid Market Challenges
Read More
Trendline
ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026
ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026
Read More
Trendline
EarthLabs Reports $34M Profit for FY2025 Amid Significant Investment Gains
EarthLabs Reports $34M Profit for FY2025 Amid Significant Investment Gains
Read More
Trendline
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings
Read More
Trendline
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
Read More
Trendline
Ituran Location and Control Ltd. Announces Q1 2026 Results Release
Ituran Location and Control Ltd. Announces Q1 2026 Results Release
Read More
Trendline
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Read More